Search Results - "Bruno García del Blanco"
-
1
Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification
Published in Circulation Journal (2016)“…Background:The effects of dual antiplatelet therapy (DAPT) and triple therapy (TT: DAPT plus oral anticoagulation) in patients with atrial fibrillation (AF)…”
Get full text
Journal Article -
2
Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia
Published in Journal of cardiovascular electrophysiology (01-03-2019)“…Background Radiofrequency ablation (RF) of ventricular tachycardia (VT) due to intramural foci has a high recurrence rate. Several techniques, such as bipolar…”
Get full text
Journal Article -
3
Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Published in PloS one (01-01-2016)“…Selecting an ideal antithrombotic therapy for elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) can be…”
Get full text
Journal Article -
4
On the Stability of Stable Coronary Artery Disease
Published in Journal of the American College of Cardiology (02-05-2017)“…Corresponding Author…”
Get full text
Journal Article -
5
A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent-In-Stent Restenosis: The RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs. Everolimus-eluting Stent)
Published in Journal of the American College of Cardiology (15-04-2014)“…This study sought to compare the efficacy of drug-eluting balloons (DEB) with that of everolimus-eluting stents (EES) in patients with bare-metal stents (BMS)…”
Get full text
Journal Article -
6
Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation: Impact on Late Clinical Outcomes and Left Ventricular Function
Published in Circulation (New York, N.Y.) (18-03-2014)“…Very few data exist on the clinical impact of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation. The objective of this study…”
Get full text
Journal Article -
7
-
8
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
Published in European heart journal (31-03-2022)“…Abstract Aim Patients with diabetes mellitus are at high risk of adverse events after percutaneous revascularization, with no differences in outcomes between…”
Get full text
Journal Article -
9
Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis
Published in Heart (British Cardiac Society) (01-09-2015)“…Mitral regurgitation (MR) is a common entity in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR), but its influence on…”
Get more information
Journal Article -
10
Coronary Artery Calcium Score Predicts Major Adverse Cardiovascular Events in Stable Chest Pain
Published in Radiology (01-03-2024)“…Background Coronary artery calcium (CAC) has prognostic value for major adverse cardiovascular events (MACE) in asymptomatic individuals, whereas its role in…”
Get more information
Journal Article -
11
-
12
Quantification of myocardial area at risk in the absence of collateral flow: The validation of angiographic scores by myocardial perfusion single-photon emission computed tomography
Published in Journal of nuclear cardiology (01-02-2013)“…Our study aimed to compare the area at risk (AAR) determined by single-photon emission computed tomography (SPECT) with the Bypass Angioplasty…”
Get full text
Journal Article -
13
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Published in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (01-12-2020)“…The MAGSTEMI trial showed larger endothelium-independent vasodilatation with magnesium-based bioresorbable scaffolds (MgBRS) than with sirolimus-eluting stents…”
Get more information
Journal Article -
14
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score–Matched Analysis
Published in Circulation. Cardiovascular interventions (01-03-2018)“…BACKGROUND—Chronic liver disease is a known risk factor for perioperative morbidity and mortality in patients undergoing cardiac surgery. Very little data…”
Get full text
Journal Article -
15
Prognostic Value of an Abnormal Ankle–Brachial Index in Patients Receiving Drug-Eluting Stents
Published in The American journal of cardiology (01-11-2011)“…Advanced atherosclerotic disease increases the risk of stent thrombosis after drug-eluting stent (DES) implantation. We aimed to determine if an abnormal…”
Get full text
Journal Article -
16
MAGnesium‐based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design
Published in Catheterization and cardiovascular interventions (01-01-2019)“…Aim Use of a Bioresorbable Scaffolds (BRS) either in clinical practice or in the setting of an acute myocardial infarction (MI) is controversial. Despite an…”
Get full text
Journal Article -
17
Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients
Published in Circulation. Cardiovascular interventions (01-11-2018)“…BACKGROUND:The impact of preexisting left bundle branch block (LBBB) in transcatheter aortic valve replacement (TAVR) recipients is unknown. The aim of this…”
Get full text
Journal Article -
18
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial
Published in EuroIntervention (01-06-2021)“…The BioFreedom drug-coated stent with a stainless steel platform (BF-SS) has been demonstrated to be efficacious in patients at high bleeding risk and…”
Get full text
Journal Article -
19
Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation
Published in Circulation (New York, N.Y.) (07-09-2010)“…Predictors of antiplatelet therapy discontinuation (ATD) during the first year after drug-eluting stent implantation are poorly known. This was a prospective…”
Get full text
Journal Article -
20